Quantcast
Last updated on April 16, 2014 at 17:34 EDT

Latest glioblastoma multiforme Stories

2013-01-29 08:30:41

BETHESDA, Md., Jan. 29, 2013 /PRNewswire/ -- Northwest Biotherapeutics (NASDAQ: NWBO) (NW Bio), a biotechnology company developing DCVax(®) personalized immune therapies for cancer, announced today that Dr. Marnix Bosch, the Company's Chief Technical Officer, will be presenting at the Phacilitate Cell And Gene Therapy Forum 2013, today at 3:30 pm in a session entitled Clinical Development Updates: Oncology. The conference is being held at the Grand Hyatt Hotel at 10(th) and H...

2013-01-26 23:02:38

Voices Against Brain Cancer responds to an article that reports on new research suggesting that a more focused form of radiation treatment can be more effective for treating brain tumors. New York, NY (PRWEB) January 26, 2013 On January 26, Voices Against Brain Cancer (VABC) responds to a recent article published by Health.com regarding a new form of radiation treatment that has the potential to be a more effective tool in the fight against brain cancer. New research suggests that the use...

2013-01-25 12:25:40

VANCOUVER, British Columbia and MENLO PARK, Calif., Jan. 25, 2013 /PRNewswire/ -- DelMar Pharmaceuticals, Inc. (OTCQB: BRRY) ("DelMar") today announced the successful acquisition (the "Acquisition"), through a share exchange agreement, of all of the outstanding shares of Del Mar Pharmaceuticals (BC) Ltd., a clinical and commercial stage drug development company with a focus on the treatment of cancer. Concurrent with the Acquisition, DelMar completed the first closing in a private placement...

2013-01-24 13:43:18

New method is first to predict brain cancer outcome and quickly show if therapy is effective The critical question shortly after a brain cancer patient starts treatment: how well is it working? But there hasn't been a good way to gauge that. Now Northwestern Medicine researchers have developed a new method -- similar to forecasting storms with computer models -- to predict an individual patient's brain tumor growth. This growth forecast will enable physicians to rapidly identify how...

2013-01-22 12:27:50

ST. HELIER, Jersey, Jan. 22, 2013 /PRNewswire/ -- Novocure Limited announced today that Novocure's NovoTTF(TM) Therapy has been added to the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Central Nervous System Cancers. The new NCCN Guidelines® indicate that physicians consider using NovoTTF Therapy as a new option, in addition to surgery, chemotherapy, and radiation, for patients with glioblastoma brain tumors that recur or progress after initial treatment. The...

2013-01-19 23:00:22

Voices Against Brain Cancer offers support to Heather Knies, a now cancer free mother who battled two brain tumors. New York, NY (PRWEB) January 19, 2013 On January 19, Voices Against Brain Cancer (VABC) congratulates Heather Knies, who beat two brain tumors and is now cancer free and the mother of a seven-month-old daughter. Knies was diagnosed with two brain tumors at age 24. ABC News states that while this is on the young side, doctors say that people can get brain cancer at any age,...

2013-01-14 23:01:42

The Chris Elliott Fund's monthly Brains Matter Webinar Series will be sharing the latest advancements in brain tumor treatments while also connecting patients and caregivers with national specialists. This webinar series is part of the Chris Elliott Fund's plan grow our team of rockstar healthcare advocates. Seattle, Wash. (PRWEB) January 14, 2013 The Chris Elliott Fund (CEF) is pleased to announce the first of several webinars that will be offered monthly, and free of charge, by the...

2013-01-08 12:26:34

ST. HELIER, Jersey, Jan. 8, 2013 /PRNewswire/ -- Novocure Limited announced today the appointment of Louis J. Lavigne Jr., James T. Lenehan, Robert J. Mylod Jr. and Charles G. Phillips III to its board of directors. The new members are independent directors and provide Novocure extensive financial and healthcare industry expertise. Novocure is a private, commercial stage oncology company dedicated to the development and commercialization of NovoTTF(TM) Therapy, its novel and proprietary...

2013-01-07 08:30:24

VANCOUVER, British Columbia, Jan. 7, 2013 /PRNewswire/ -- Del Mar Pharma today announced that the European Committee for Orphan Medicinal Products (COMP) has recommended the designation of VAL-083 as an orphan medicinal product for the treatment of glioma. The COMP recommendation will be ratified by the European Commission in accordance with Article 5(8) of Regulation (EC) No. 141/2000. Glioma is a type of tumor that starts in the brain or spine and includes glioblastoma multiforme (GBM),...

2013-01-06 05:02:12

Following an article highlighting Greg Cantwell, a brain cancer survivor who is now mentoring others in the fight against cancer, Voices Against Brain Cancer offers a response. New York, NY (PRWEB) January 05, 2013 On January 5, Voices Against Brain Cancer (VABC) reacts to the efforts of cancer survivor Greg Cantwell, who is mentoring people who are fighting cancer. As a survivor of brain cancer himself, Greg Cantwell is familiar with the feeling of despair that can come with being...